Academic Integrity: tutoring, explanations, and feedback — we don’t complete graded work or submit on a student’s behalf.

1-inyour opinion, where will healthcare care systems see the greatest return on

ID: 432531 • Letter: 1

Question

1-inyour opinion, where will healthcare care systems see the greatest return on investment? Waste? Fraud? Or is there some other cost saving mechanism that the course misses?

2)

"Some of these are controlling fees and provider incomes, cutting the price of pharmaceuticals and other supplies, reducing administrative waste, eliminating medical interventions of no benefit, substituting less costly technologies that are equally effective, and increasing the provision of those preventative services that cost less than the illnesses they prevent. " Great summary, Nathan.

In our text, Bodenheimer talks about Mechanisms for Controlling Costs. (Chapter 9, 2012). These are not the only recommendations to be familiar with. I have attached the CDC's Preventive Care Guidelines for 2017. It gives age ranges for certain testing. On some of the tests ages that have caused controversy about age ranges, they have simply put 'Talk to your doctor'. There is also a Guideline for those over 65. It cuts off many tests, such as mammography, after age 75 as unnecessary, men over 65 are no longer recommended PSAs.

Class,
What do you think? What would be more effective in controlling costs? Why?

Explanation / Answer

According to me, the greatest opportunity for healthcare system lies in removal of fraud.

The healthcare system is unbalanced across the world. In the developed countries the healthcare system is often provided to people using insurance and controlled by the pharma companies. However, in the developing nations where people usually do not have insurance the cost of healthcare is directly borne by the patient and the families. If we look at these matters carefully, we can easily see that the cost of medication and pharmaceutical products vary drastically across different countries. This is often not due to logistics but due to the regulations that has been imposed by pharmaceutical companies.

This makes medication expensive in the developed nations and cheaper in the developing countries. In one way this can be considered a globally organized fraud. If the global agencies and governments take action, it is possible to achieve much more for the healthcare system. This will in turn control costs and the variance of the costs across different countries.